Michael Landsittel, CFO: Blueprint Medicines BPMC Sell · Filed 24/05/17

Trade details

Type: Insider sale
Amount: $266,424.62
Shares · price: 2,486 sh · $107.17 a share
Held after: 72,981 sh
Stock: Blueprint Medicines BPMC
Person: Michael LandsittelCFO
Trade date: 24/05/15
Filed: 24/05/17
Days to filing: 2 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Blueprint Medicines trades, last 26 weeks

What else happened in Blueprint Medicines around then

Filed or reported within 30 days of the trade day · 24/04/15~24/06/14

Michael Landsittel's recent trades

Michael LandsittelCFO
SellBlueprint Medicines
Sell
Blueprint Medicines
BPMC
$469.2K
5,284 sh
$469.2K
Filed 25/03/07
Traded 25/03/05
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$419.9K
4,409 sh
$419.9K
Filed 24/08/19
Traded 24/08/15
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$145.3K
1,364 sh
$145.3K
Filed 24/05/17
Traded 24/05/15
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$1.1M
10,000 sh
$1.1M
Filed 24/05/06
Traded 24/05/02
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$475K
5,000 sh
$475K
Filed 24/04/01
Traded 24/03/28

Michael Landsittel, CFO — sold $266.4K of Blueprint Medicines BPMC · 3.3% of holdings · 10b5-1 plan | Whalegun